Related Experiment Video
Updated: Oct 12, 2025

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
Yu-Ching Wen1,2,3, Yen-Nien Liu4, Hsiu-Lien Yeh5
1Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Abstract:
Neuroendocrine differentiation (NED) is associated with WNT signaling activation and can be significantly observed after failure of androgen-deprivation therapy (ADT) for prostatic adenocarcinomas. Cytokine signaling is stimulated in NED prostate cancer; however, how ADT-upregulated WNT signaling promotes activation of cytokine signaling and contributes to NED of prostate cancer is poorly understood. In this study, we identified ADT-mediated upregulation of transcription factor 7 like 1 (TCF7L1), which increases the cytokine response and enhances NED of prostate cancer through interleukin (IL)-8/C-X-C motif chemokine receptor type 2 (CXCR2) signaling activation. ADT induced the secretion of WNT4 which upon engagement of TCF7L1 in prostate cancer cells, enhanced IL-8 and CXCR2 expressions. TCF7L1 directly binds to the regulatory sequence region of IL-8 and CXCR2 through WNT4 activation, thus upregulating IL-8/CXCR2 signaling-driven NED and cell motility. Analysis of prostate tissue samples collected from small-cell neuroendocrine prostate cancer (SCPC) and castration-resistant prostate cancer (CRPC) tumors showed an increased intensity of nuclear TCF7L1 associated with CXCR2. Our results suggest that induction of WNT4/TCF7L1 results in increased NED and malignancy in prostate cancer that is linked to dysregulation of androgen receptor signaling and activation of the IL-8/CXCR2 pathway.
Insights
Androgen-deprivation therapy failure in prostate cancer activates WNT4/TCF7L1 signaling, increasing Interleukin-8/CXCR2 expression. This promotes neuroendocrine differentiation and malignancy, driving prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- Neuroendocrine differentiation (NED) in prostate cancer is linked to WNT signaling activation, particularly after androgen-deprivation therapy (ADT) failure.
- The precise mechanisms by which ADT-induced WNT signaling promotes cytokine signaling and contributes to NED remain unclear.
Purpose of the Study:
- To elucidate the role of ADT-upregulated WNT signaling in activating cytokine signaling and driving prostate cancer NED.
- To identify key molecular players involved in the transition to a neuroendocrine phenotype following ADT.
Main Methods:
- Investigated the expression and function of transcription factor 7 like 1 (TCF7L1) in prostate cancer cells under ADT conditions.
- Analyzed the impact of WNT4 and TCF7L1 on Interleukin-8 (IL-8) and CXCR2 expression.
- Examined the binding of TCF7L1 to regulatory regions of IL-8 and CXCR2.
- Assessed TCF7L1 and CXCR2 levels in clinical samples of small-cell prostate cancer and castration-resistant prostate cancer.
Main Results:
- ADT upregulates TCF7L1, which enhances cytokine response and promotes NED via IL-8/CXCR2 signaling.
- ADT induces WNT4 secretion, leading to TCF7L1 engagement and increased IL-8 and CXCR2 expression.
- TCF7L1 directly binds to IL-8 and CXCR2 regulatory regions, upregulating IL-8/CXCR2-driven NED and cell motility.
- Clinical samples show increased nuclear TCF7L1 and CXCR2 in neuroendocrine and castration-resistant prostate cancer.
Conclusions:
- WNT4/TCF7L1 induction drives NED and malignancy in prostate cancer by dysregulating androgen receptor signaling and activating the IL-8/CXCR2 pathway.
- Targeting the WNT4/TCF7L1/IL-8/CXCR2 axis may offer therapeutic strategies for advanced prostate cancer.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Master Transcription Regulators
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply

